Home Cart Sign in  
Chemical Structure| 885434-70-8 Chemical Structure| 885434-70-8

Structure of HJC0350
CAS No.: 885434-70-8

Chemical Structure| 885434-70-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

HJC0350 is a potent and selective EPAC2 inhibitor with IC50 of 0.3 μM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of HJC0350

CAS No. :885434-70-8
Formula : C15H19NO2S
M.W : 277.38
SMILES Code : CC1=CN(S(=O)(C2=C(C)C=C(C)C=C2C)=O)C(C)=C1
MDL No. :MFCD05144768
InChI Key :AFZWZVLPIMHLSE-UHFFFAOYSA-N
Pubchem ID :22200891

Safety of HJC0350

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H332-H372-H400
Precautionary Statements:P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501
Class:9
UN#:3077
Packing Group:

Related Pathways of HJC0350

GPCR

Isoform Comparison

Biological Activity

Target
  • EPAC2

    EPAC2, IC50:0.3 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
Min6 cells 0.3 μM 30 minutes inhibitory effects of the insulinotropic function of AWRK6 Int J Mol Sci. 2018 Oct 7;19(10):3053
HEK293/AKAR3 cells 10 µM To test the inhibitory effect of HJC0350 on PKA, results showed that HJC0350 did not affect the activation of PKA by 8-Br-cAMP-AM J Med Chem. 2013 Feb 14;56(3):952-62
HEK293/EPAC2-FL cells 10 µM To test the inhibitory effect of HJC0350 on EPAC2, results showed that HJC0350 fully blocked the 007-AM induced FRET changes J Med Chem. 2013 Feb 14;56(3):952-62
RAW 264.7 cells 0.3 µmol/L 24 hours Evaluate the effect of HJC-0350 on inflammatory response in RAW 264.7 cells. Results showed that HJC-0350 enhanced phosphorylation of NF-κB p65 and p38 MAPK. J Cell Mol Med. 2022 Jan;26(1):216-227
Caco-2 cells 0.3 µmol/L 24 hours Evaluate the effect of HJC-0350 on LPS-induced damage in Caco-2 cells. Results showed that HJC-0350 did not ameliorate LPS-induced monolayer damage. J Cell Mol Med. 2022 Jan;26(1):216-227

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Il-10−/− mice Spontaneous colitis model Intraperitoneal injection 0.5 mg/kg Every 2 days for 4 weeks Evaluate the effect of HJC-0350 on spontaneous colitis. Results showed that HJC-0350 exacerbated colitis symptoms, increased inflammatory factor expression, and intestinal permeability. J Cell Mol Med. 2022 Jan;26(1):216-227

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.61mL

0.72mL

0.36mL

18.03mL

3.61mL

1.80mL

36.05mL

7.21mL

3.61mL

References

 

Historical Records

Categories